XORTX Therapeutics Aktie - ANU

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

XORTX Welcomes New Member to the Board of Directors

CALGARY, Alberta, Jan. 02, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Announces US ATM Offering

CALGARY, Alberta, Nov. 30, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Meets Nasdaq Continued Listing Requirements

CALGARY, Alberta, Nov. 29, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Clarifies Timing for Share Consolidation

CALGARY, Alberta, Nov. 10, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Announces Share Consolidation

CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023

● Preclinical Findings Help Clarify and Reinforce the Role of Uric Acid in the Pathogenesis of Polycystic...

XORTX Announces Results of Special Meeting of Shareholders

CALGARY, Alberta, Oct. 27, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Announces Rescheduling of Special Meeting of Shareholders

CALGARY, Alberta, Oct. 25, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”...

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

ISS, a leading proxy advisory firm, recommends XORTX Therapeutics Inc.’s shareholders vote FOR the share...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

ANU - Frequently Asked Questions (FAQ)

What is the current XORTX Therapeutics share price?

The current share price of XORTX Therapeutics is 0,00 €

What is the 1 year trading range for XORTX Therapeutics share price?

XORTX Therapeutics has traded in the range of 0,00 € to 0,00 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
Z620Trillion Energy International Inc	0,0359 € (50,21%)	1,72M
WDL1Nakiki SE	0,385 € (32,30%)	47,26k
K8DWellfield Technologies Inc	0,0106 € (29,27%)	1,67k
M0LYGreenland Resources Inc	0,73 € (21,67%)	6,4k
1ZYMedaro Mining Corp	0,1334 € (19,32%)	6k
7KOCullinan Metals Corp	0,009 € (-48,86%)	50
E3O1Nexoptic Technology Corp	0,0055 € (-31,25%)	20,89k
PU11Social Chain AG	0,0145 € (-27,50%)	50
YTRAurelia Metals	0,127 € (-24,85%)	18,79k
I63Lighton	8,845 € (-21,38%)	2,65k
E3BEutelsat Communications	2,84 € (-13,94%)	3,46M
DMLSayona Mining Limited	0,0088 € (0,00%)	3,2M
D7GNel ASA	0,2078 € (2,87%)	3M
N04NuCana plc	0,105 € (-2,78%)	1,95M
Z620Trillion Energy International Inc	0,0359 € (50,21%)	1,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

XORTX Therapeutics Inc (ANU)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

ANU Neueste Nachrichten

XORTX Welcomes New Member to the Board of Directors

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Share Consolidation

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

ANU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

XORTX Therapeutics Inc (ANU) Börsenkurse

XORTX Therapeutics Inc (ANU)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

ANU Neueste Nachrichten

XORTX Welcomes New Member to the Board of Directors

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Share Consolidation

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

ANU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE